FDA Extends NDA Review for Neuromed Pharmaceuticals's Exalgo(TM) Extended-Release Tablets
11/20/2009 8:31:56 AM
More...
|
CombinatoRx, Incorporated (CRXX) And Neuromed Pharmaceuticals Receive FDA Feedback on New Drug Application for Exalgo Extended-Release Tablets
11/16/2009 9:40:13 AM
More...
|
CombinatoRx, Incorporated (CRXX) Reports Financial Results for the Third Quarter 2009
11/3/2009 8:54:14 AM
More...
|
CombinatoRx, Incorporated (CRXX)'s Synavive (CRx-102) Maintains Efficacy Throughout 12 Month Phase 2 Knee OA Extension Trial
10/21/2009 7:45:54 AM
More...
|
CombinatoRx, Incorporated (CRXX)-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis K.K. Through Proposed Acquisition of Fovea Pharmaceuticals
10/5/2009 9:58:57 AM
More...
|
CombinatoRx, Incorporated (CRXX) Stock Trading Halted Today; FDA Advisory Committees Meet to Discuss Exalgo
9/23/2009 7:09:01 AM
More...
|
CombinatoRx, Incorporated (CRXX) and Neuromed Pharmaceuticals Announce Posting of Briefing Documents for FDA Advisory Committee
9/22/2009 9:11:03 AM
More...
|
Clinical Data, CombinatoRx, Incorporated (CRXX) Strike Deal; Potential $252 Million in Milestones
8/13/2009 8:56:29 AM
More...
|
CombinatoRx, Incorporated (CRXX) Reports Financial Results for the Second Quarter 2009
8/10/2009 9:34:31 AM
More...
|
CombinatoRx, Incorporated (CRXX) to Webcast Conference Call Discussing Second Quarter 2009 Financial Results
7/31/2009 9:17:43 AM
More...
|
|